First-Line Treatment for Alcohol Withdrawal Syndrome

Introduction to Benzodiazepine Treatment

Benzodiazepines are the gold standard first-line treatment for managing alcohol withdrawal syndrome due to their efficacy in reducing withdrawal symptoms and preventing seizures and delirium tremens, as recommended by medical guidelines 1, 2

Long-acting benzodiazepines (diazepam and chlordiazepoxide) are preferred for most patients as they provide better protection against seizures and delirium tremens due to their longer duration of action 1, 2
Chlordiazepoxide is an alternative option at doses of 25-100 mg every 4-6 hours orally 1, 2

Short and intermediate-acting benzodiazepines (lorazepam, oxazepam) are safer in patients with advanced age, hepatic dysfunction, respiratory failure, obesity, and recent head trauma 1, 2
Lorazepam is typically administered at 1-4 mg every 4-8 hours (6-12 mg/day) and doesn't rely on hepatic oxidation, making it safer for patients with liver impairment 1, 2

Thiamine (100-300 mg/day) must be administered to all patients with alcohol withdrawal to prevent Wernicke encephalopathy 1, 2
Thiamine should always be given before any glucose-containing IV fluids to prevent precipitating acute thiamine deficiency 2
Carbamazepine (200 mg every 6-8 hours) can be used as an alternative for seizure prevention 2
Haloperidol (0.5-5 mg every 8-12 hours) may be used carefully for agitation or psychotic symptoms not controlled by benzodiazepines 2

Inpatient treatment is recommended for patients with serious complications, co-occurring serious medical or psychiatric illness, and failure of outpatient treatment 1, 2

The Clinical Institute Withdrawal Assessment for Alcohol Scale, Revised (CIWA-Ar) can guide treatment intensity—scores >8 indicate moderate AWS and scores ≥15 indicate severe AWS requiring more aggressive treatment 2
Treatment with benzodiazepines should be tapered following resolution of withdrawal symptoms 2
Treatment duration should not exceed 10-14 days to avoid the risk of benzodiazepine dependence 2

Disulfiram should be avoided in patients with severe alcoholic liver disease due to potential hepatotoxicity 1, 3
Naltrexone is not recommended in patients with alcoholic liver disease due to potential hepatotoxicity 1, 3
The CIWA protocol should not be used alone for diagnosis of AWS as high scores may be seen in other conditions 2